Compare AEHR & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEHR | SGP |
|---|---|---|
| Founded | 1977 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.8M | 932.9M |
| IPO Year | 1997 | N/A |
| Metric | AEHR | SGP |
|---|---|---|
| Price | $36.69 | $26.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $21.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.6M | 93.8K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,968,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $72.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.27 | $24.71 |
| 52 Week High | $46.95 | $30.56 |
| Indicator | AEHR | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 45.94 |
| Support Level | $20.22 | $25.66 |
| Resistance Level | $46.95 | $29.83 |
| Average True Range (ATR) | 4.00 | 1.63 |
| MACD | -0.89 | -0.15 |
| Stochastic Oscillator | 25.61 | 20.75 |
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.